Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iontophoresis-assisted AFL-PDT for Actinic Keratosis
NCT02670655Phase 1Completed
- Sponsor
- Dong-A University
- Start
- Jun 2014
- Primary completion
- Dec 2015
- Modality
- Light/Condition-Responsive Prodrugs
01
Overview
Phase 1, randomised, open-label trial of methyl aminolevulinate in actinic keratosis (AK) (3 arms), sponsored by Dong-A University. Primary endpoints: Short-term complete response rates at 3 months, Long-term complete response rates at 12 months and 1 more. Started Jun 2014; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02670655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02670655.